Episode 126
Dr. Noshene Ranjbar
The tragic death of Mahsa Amini, a 22-year-old woman who died in Iran’s capital of Tehran while in police custody on September 16, 2022, has sparked outrage and protests in Iran and all over the world. In this 2-part series, we sit down with Dr. Noshene Ranjbar, trauma expert and Associate Clinical Professor of Psychiatry at the University of Arizona, to discuss both the trauma and hope surrounding the fight for freedom in Iran.
Episode 125
Keith Kurlander, MA, LPC
Dr. Will Van Derveer
In part two of this series, we’ll continue our conversation on psychedelic therapy integration as we discuss the ins and outs of this process. Listen in as we talk about issues such as fragmentation, that can sometimes occur after a dosing session. We’ll also discuss the rare instances in which integration may not be possible.
Episode 124
Keith Kurlander, MA, LPC
Dr. Will Van Derveer
Integration is a key component of the psychedelic therapy healing process. Integration sessions can often help a client unpack material that arose during the psychedelic session that wasn’t completely digested and sequenced in the client’s body. In this episode, we’ll discuss advanced integration topics of psychedelic therapy, as well some stories of what can happen without proper integration.
Episode 123
Dr. Daniel Emina
In part 2 of this series, we continue the conversation with Dr. Daniel Emina about the use of SPECT brain scans in studying blood flow patterns that correlate with symptom clusters. Listen in as we dive a little deeper and talk about the process used to analyze data from SPECT scans to help create treatment plans for patients experiencing mental illness symptoms.
Episode 122
Josh Kappel
In today’s episode, we have the timely opportunity to discuss Colorado Proposition 122 with one of its co-authors, attorney Josh Kappel. The Natural Medicine Health Act of Colorado would create a pathway to legalize psilocybin therapy in Colorado, and contains some very interesting nuances that make this initiative revolutionary and distinct from other state initiatives. We’ll talk about what this means for therapists, practitioners, and other facilitators. Join us as we dig into the details with drug policy reform advocate and founding partner of Vicente Sederberg law firm, Josh Kappel.
Episode 121
Dr. Daniel Emina
In this episode, we sit down with Dr. Daniel Emina, Psychiatrist and Associate Medical Director at Amen Clinics, to discuss SPECT brain scans and the role that this revolutionary technology has in the field of integrative psychiatry. During this two-part series we’ll talk about the advantages of SPECT brain scans and even some of the controversy surrounding this type of imaging.
Episode 120
Keith Kurlander, MA, LPC
Dr. Will Van Derveer
In today’s episode, we discuss the new & exciting developments that are happening in Oregon, surrounding the Ballot Measure 109, which refers to the regulatory licensing and use of psilocybin products and services. Listen in as we go over details of this new Oregon law as we understand it, the risks and advantages of psilocybin as a therapeutic model, and a somewhat similar initiative that will be on Colorado’s ballot this coming November.
Episode 119
Dr. Gabor Maté
In today’s episode, we’re joined by renowned speaker and bestselling author, Dr. Gabor Maté, to discuss his latest book entitled “The Myth of Normal: Trauma, Illness and Healing in a Toxic Culture”. Listen in as we discuss some of the highlights of the book, including the causes of illness, the effect that toxic culture has on our minds and bodies, and a pathway to health and healing.